Basilea's Toctino (alitretinoin) receives marketing authorization in France
24-Oct-2008 -
Basilea Pharmaceutica Ltd. announced that Toctino® (alitretinoin), a once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been approved by the French Health Products Safety Agency (Agence Française de Sécurité Sanitaire des ...
chronic hand eczema
regulatory approval
Switzerland